Marie Öhman

With deep sorrow we inform the greater research community that Professor Marie Öhman passed away on February 3, 2019. Her death was the consequence of an aggressive form of colon cancer, first diagnosed in latter half of June 2018. Subsequent attempts to combat the disease failed. Clearly, her passing came much too early in life; Marie would have turned 55 at the end of March. She left this world riding high on recent successes. Her research was well-funded and she has a suit of recent publications derived from an active research group currently comprised of a senior researcher and three talented doctoral students.

Scientifically, Marie was a respected researcher with an internationally leading role in the field of RNA biology. The focus of her research was directed at understanding the physiological consequences of adenosine to inosine (A-to-I) RNA editing. A-to-I editing has the power to recode mRNAs, and has the potential to change the sequence of non-coding RNAs, such as microRNAs. Editing has garnered growing attention due to its fundamental importance in the regulation of neurotransmission. The cutting-edge research carried out in the Öhman laboratory addresses the regulation and function of RNA editing in neurons, and her research group has made significant contributions regarding the role of editing in brain development and neuronal activity.

Marie’s colleagues, at the Department of Molecular Biosciences, The Wenner-Gren Institute (MBW) and the biology departments at Stockholm University, remember Marie for her intense interest in science, her great knowledge as a molecular biologist, and her enthusiasm as a teacher. Marie was an exceptional colleague and friend to many, and she will be deeply missed. Her passing leaves a huge void for us here in Stockholm and the international RNA research community.

Our condolences go out to Marie’s family, her two sons and husband, along with her brother and extended family.